Dr Matt Brown

The Royal Marsden Hospital

Matt Brown is a consultant in pain medicine at the Royal Marsden Hospital. He trained at King’s College London, winning the War Memorial and Wolfson Foundation Scholarships and graduating with distinction.
His clinical training in pain medicine was conducted at The Royal National Orthopaedic Hospital and the National Hospital for Neurology and Neurosurgery. Matt fulfilled his long-term interest in clinical research by gaining a National Institute for Health Research’s Academic Clinical Fellowship. This enabled him to conduct novel, award-winning research into pain at both Imperial College and King’s College, London. Subsequently Matt completed a Doctorate in Medicine at the Institute of Cancer Research (becoming the first anaesthetist in the Institute’s history to do so and winning the Chairman’s Prize at graduation).
Matt has published and lectured widely on the subject of pain in cancer. His research interests include pain in cancer survivors, persistent post-surgical pain, chemotherapy induced peripheral neuropathy (CIPN) and the use of high-intensity focused ultrasound (HIFU) to reduce pain from bone metastases.

dont miss

Pain in Cancer – New Horizons

As the oncological landscape shifts in response to the improved diagnosis and treatment of malignancy, so the causes and types of pain encountered in cancer patients change. Pain is the most feared symptom of patients with advanced cancer and remains a major area of unmet clinical need. Poorly controlled pain results in markedly reduced quality of life and commonly impacts on treatment compliance and overall clinical outcomes. This seminar will provide an overview of current hot-topics in the field of cancer pain including; chemotherapy induced peripheral neuropathy, pain in cancer survivors and the challenges posed by the ‘opioid crisis’.

EVEN MORE SEMINARS

  • Mr Naga Venkatesh Jayanthi MD, FRCS: Speaking at the Oncology Convention

    Mr Naga Venkatesh Jayanthi MD, FRCS
    Bupa - Consultant Surgeon

    Minimal Invasive Oesophagectomy – where are we going?

  • Prof Samuel Janes: Speaking at the Oncology Convention

    Prof Samuel Janes
    University College London Hospitals

    Coming soon

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment

  • Michael Schreiber: Speaking at the Oncology Convention

    Michael Schreiber
    Brain Tumor Foundation, Chairman

    Brain Tumors - Innovation, support and advocacy

  • Stéfan Halbherr: Speaking at the Oncology Convention

    Stéfan Halbherr
    InnoMedica

    Liposome pipeline addressing unmet medical needs in oncology, imaging, and neurodegeneration